Fosamax MDL Plaintiff Takes Case To 2nd Circ.

Law360, New York (December 22, 2009, 4:24 PM EST) -- Bessie Flemings, a Mississippi woman whose bellwether case over Merck & Co. Inc. osteoporosis drug Fosamax was dismissed Nov. 23, has appealed the district court's finding that her expert witnesses failed to show a connection between the drug and a degenerative jawbone disease.

The notice of appeal to the U.S. Court of Appeals for the Second Circuit was filed Monday, about a month after Judge John F. Keenan of the U.S. District Court for the Southern District of New York, who is overseeing the Fosamax multidistrict...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.